The development and characterization of an E. coli O25B bioconjugate vaccine
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The development and characterization of an E. coli O25B bioconjugate vaccine
Authors
Keywords
-
Journal
GLYCOCONJUGATE JOURNAL
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-17
DOI
10.1007/s10719-021-09985-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trial
- (2019) Robert W Frenck et al. LANCET INFECTIOUS DISEASES
- Safety, tolerability and immunogenicity of the ExPEC4V (JNJ-63871860) vaccine for prevention of invasive extraintestinal pathogenic Escherichia coli disease: A phase 1, randomized, double-blind, placebo-controlled study in healthy Japanese participants
- (2018) Megumi Inoue et al. Human Vaccines & Immunotherapeutics
- Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial
- (2017) Angela Huttner et al. LANCET INFECTIOUS DISEASES
- Immunogenicity and safety of a tetravalent E. coli O-antigen bioconjugate vaccine in animal models
- (2016) Germie P.J.M. van den Dobbelsteen et al. VACCINE
- Purification and characterization of aShigellaconjugate vaccine, produced by glycoengineeringEscherichia coli
- (2015) Neil Ravenscroft et al. GLYCOBIOLOGY
- Extraintestinal PathogenicEscherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field
- (2015) Jan T. Poolman et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: A single blind, partially randomized Phase I study
- (2015) Christoph F.R Hatz et al. VACCINE
- Biosynthesis and Export of Bacterial Lipopolysaccharides
- (2014) Chris Whitfield et al. Annual Review of Biochemistry
- Diagnostic Potential of Monoclonal Antibodies Specific to the Unique O-Antigen of Multidrug-Resistant Epidemic Escherichia coli Clone ST131-O25b:H4
- (2014) Valéria Szijártó et al. Clinical and Vaccine Immunology
- Glycoconjugate vaccines: an update
- (2014) Mairi Vella et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Bacterial self-defence: howEscherichia colievades serum killing
- (2014) Helen Miajlovic et al. FEMS MICROBIOLOGY LETTERS
- Development of Vi conjugate – a new generation of typhoid vaccine
- (2013) Shousun Chen Szu Expert Review of Vaccines
- Prevention of Staphylococcus aureus Infections by Glycoprotein Vaccines Synthesized in Escherichia coli
- (2013) Michael Wacker et al. JOURNAL OF INFECTIOUS DISEASES
- The Serum Resistome of a Globally Disseminated Multidrug Resistant Uropathogenic Escherichia coli Clone
- (2013) Minh-Duy Phan et al. PLoS Genetics
- The structure of the O-specific polysaccharide of the lipopolysaccharide from Yersinia enterocolitica serotype O:50 strain 3229
- (2012) Agnieszka Beczała et al. CARBOHYDRATE RESEARCH
- Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component
- (2012) Michael Wetter et al. GLYCOCONJUGATE JOURNAL
- Ifenprodil restores GDNF-evoked Ca2+ signalling and Na+/K+-ATPase expression in inflammation-pretreated astrocytes
- (2011) Christopher Lundborg et al. JOURNAL OF NEUROCHEMISTRY
- Escherichia coliSequence Type ST131 as the Major Cause of Serious Multidrug‐ResistantE. coliInfections in the United States
- (2010) James R. Johnson et al. CLINICAL INFECTIOUS DISEASES
- Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain
- (2010) B. A. Rogers et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Production of glycoprotein vaccines in Escherichia coli
- (2010) Julian Ihssen et al. Microbial Cell Factories
- Gene doctoring: a method for recombineering in laboratory and pathogenic Escherichia coli strains
- (2009) David J Lee et al. BMC MICROBIOLOGY
- The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup
- (2008) Olivier Clermont et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation